Selective crystallization of AGOMELATINE (cas 138112-76-2) from molten state induced by polymer
-
Add time:08/17/2019 Source:sciencedirect.com
In this study, AGOMELATINE (cas 138112-76-2) Form I was selectively recrystallized from molten state induced by ethyl cellulose (EC). It was found EC could effectively inhibit the transformation process of Form I to Form II. The effect of EC on the recrystallization of agomelatine from molten state was studied in detail. Simultaneous X-ray powder diffraction (PXRD), differential scanning calorimetry (DSC), and polarized light microscopy (PLM) were used to investigate its thermodynamic performance. In addition, the stability and solubility of the Form I induced by EC were carefully explored indicating it gained more stability compared with other forms produced without EC.
We also recommend Trading Suppliers and Manufacturers of AGOMELATINE (cas 138112-76-2). Pls Click Website Link as below: cas 138112-76-2 suppliers
Prev:Research articleEffects of AGOMELATINE (cas 138112-76-2) in rotenone-induced Parkinson’s disease in rats
Next:Effects of AGOMELATINE (cas 138112-76-2) on electrocorticogram activity on penicillin-induced seizure model of rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- AGOMELATINE (cas 138112-76-2) treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light08/25/2019
- Mucoadhesive olaminosomes: A novel prolonged release nanocarrier of AGOMELATINE (cas 138112-76-2) for the treatment of ocular hypertension08/24/2019
- Behavioural pharmacologyStudies on the reproductive effects of chronic treatment with AGOMELATINE (cas 138112-76-2) in the rat08/23/2019
- Research paperEffect of AGOMELATINE (cas 138112-76-2) 25–50 mg on functional outcomes in patients with major depressive disorder08/22/2019
- Spike–Wave Discharges and Sleep–Wake States during Circadian Desynchronization: No Effects of AGOMELATINE (cas 138112-76-2) upon Re-Entrainment08/21/2019
- AGOMELATINE (cas 138112-76-2)-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus08/20/2019
- Oxymatrine ameliorates AGOMELATINE (cas 138112-76-2)-induced hepatocyte injury through promoting proteasome-mediated CHOP degradation08/19/2019
- Effects of AGOMELATINE (cas 138112-76-2) on electrocorticogram activity on penicillin-induced seizure model of rats08/18/2019
- Research articleEffects of AGOMELATINE (cas 138112-76-2) in rotenone-induced Parkinson’s disease in rats08/16/2019